Skip to search formSkip to main contentSkip to account menu

24 HR metoprolol succinate 50 MG Extended Release Oral Tablet

Known as: METOPROLOL SUCCINATE 50 mg ORAL TABLET, EXTENDED RELEASE [METOPROLOL SUCCINATE], METOPROLOL SUCCINATE 50 mg ORAL TABLET, EXTENDED RELEASE, metoprolol succinate 50 MG 24HR Extended Release Oral Tablet 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Cardiovascular disease is the most common cause of death in the world. Metoprolol tatrate is a β1 selective blocker that is used… 
2012
2012
The investigation is to study the effect of polymers on compressibility and release of Metoprolol Tartarate from tablet through… 
2010
2010
The present study was an attempt to develop bilayered chitosan containing mucoadhesive buccal patches to ensure satisfactory… 
Highly Cited
2004
Highly Cited
2004
SummaryA new controlled-release (CR) formulation of the β1-selective adrenoceptor antagonist metoprolol1 has been developed… 
1999
1999
BEta-blocker STrategy plus Implantable Cardioverter Defibrillator (BEST + ICD) Trial is a multicenter prospective randomized… 
1994
1994
1. Exercise and beta-adrenoceptor blockade have important roles in the prevention and treatment of cardiovascular disease, but… 
1990
1990
The plasma concentration‐time profile and hemodynamic effects of metoprolol after the administration of metoprolol CR/ZOK, a… 
Review
1990
Review
1990
In the development of a new controlled release preparation and its subsequent assessment there are a number of factors that need… 
1984
1984
DIE FAEHIGKEIT, BLUTALKOHOL ABZUBAUEN, IST BISHER VON KEINEM JEMALS UNTERSUCHTEN PRAEPARAT ERREICHT WORDEN. IN DER VORLIEGENDEN…